Secondary Logo

Institutional members access full text with Ovid®

Share this article on:

Etiologies and Outcomes of Pleural Effusions in Patients With Systemic Lupus Erythematosus

Palavutitotai, Nattawan MD*; Buppajarntham, Tanas MD*; Katchamart, Wanruchada MD, MSc(Clin Epi)

JCR: Journal of Clinical Rheumatology: December 2014 - Volume 20 - Issue 8 - p 418–421
doi: 10.1097/RHU.0000000000000179
Original Articles

Background Pleuritis is the most common pulmonary manifestation in systemic lupus erythematosus (SLE). In Thailand, the incidence of tuberculosis (TB) is high; moreover, treatment with immunosuppressive agents increases the risk for TB infection.

Objective The objective of this study was to examine the clinical manifestations, etiology, management, and outcomes of patients with SLE and pleural effusion in an area for TB.

Methods We studied adults satisfying the American College of Rheumatology classification criteria for SLE who presented with pleuritis between 2002 and 2010. Pleuritis was defined as having 1 of 3 of the following criteria: typical pleuritic chest pain, pleural rub, and clinical or radiological evidence of pleural effusion.

Results A total of 119 patients with 127 episodes of pleuritis/pleural effusion were included. Pleuritis was the first presentation in 47 episodes (37%) and was found accompanied with pericarditis for 16%. Most patients (81%) had active SLE in other systems. The causes of pleural effusion included lupus pleuritis (52%), tuberculous pleuritis (9%), parapneumonic effusion (7%), and transudate (15%). The diagnosis was inconclusive in 17%. The diagnosis of lupus pleuritis was made by a clinical diagnosis (47%) and by excluding other causes from pleural fluid analysis or biopsy (53%). Most patients with lupus pleuritic responded well to corticosteroid therapy.

Conclusions Lupus pleuritis is still the most common cause of pleural effusion in SLE and often reflects its disease activity. The diagnosis of lupus pleuritis is a clinical diagnosis or is performed by excluding other conditions. The treatment outcomes of lupus pleuritis are generally good.

Supplemental digital content is available in the text.

From the *Department of Internal Medicine and †Division of Rheumatology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.

Financial support was provided by Siriraj research grant.

The authors declare no conflict of interest.

Correspondence: Wanruchada Katchamart, MD, MSc(Clin Epi), Division of Rheumatology, Department of Medicine, Faculty of Medicine Siriraj Hospital, 8th Floor, Asadang Bldg, Prannok Rd, Bangkok-noi, Bangkok, Thailand 10700. E-mail: wanruchada.kat@mahidol.ac.th, wanda.katchamart@gmail.com.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s Web site (www.jclinrheum.com).

Copyright © 2014 Wolters Kluwer Health, Inc. All rights reserved.